Discover the complete record of transactions filed by Chu Yu-Waye. Director active across 1 companies, notably Fate Therapeutics INC. Cumulatively, 9 reports have been published. Total volume traded: €436k. The latest transaction was disclosed on 19 April 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.